ABBV vs BIIB: Side-by-Side Comparison
Compare Abbvie Inc (ABBV) and Biogen Inc (BIIB) side by side: market cap USD 461.26B vs USD 31.91B, P/E 128.8 vs 23.2. Financials, growth and model signals on Bullrun.
| Metric | ABBV | BIIB |
|---|---|---|
| Company | Abbvie Inc | Biogen Inc |
| Country / Exchange | United States · NYSE | United States · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-General | Drug Manufacturers-General |
| Market cap | USD 461.26B | USD 31.91B |
| P/E ratio | 128.8 | 23.2 |
| Dividend yield | 2.58% | — |
| Valuation model | 66.8% overvalued | 5.7% undervalued |
| Revenue (FY2025) | USD 61.16B | USD 9.89B |
| Revenue growth YoY | +8.6% | +2.2% |
| Net income | USD 4.23B | USD 1.29B |
| Gross margin | 70.2% | 75.7% |
| Diluted EPS | 2.36 | 8.79 |